FDA Approves Juvederm Volbella® XC
July 07, 2016Allergan announced June 1, 2016 that the FDA had approved Juvederm Volbella XC for lip augmentation and for correction of perioral rhytids. In clinical trials, Juvederm Volbella® XC was found to effective increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year.
Allergan has stated that Juvederm Volbella® XC will be available to patients in the United States in October, 2016.